Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
22 | 20104310 | intron variant | G/A;C | snv |
|
0.700 | 1.000 | 1 | 2018 | 2018 | |||||||||||
|
22 | 20108649 | non coding transcript exon variant | G/A | snv | 4.8E-02 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
0.925 | 0.080 | 22 | 20111021 | 3 prime UTR variant | G/A | snv | 6.1E-02 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.020 | 1.000 | 2 | 2013 | 2018 | |||||||
|
0.925 | 0.080 | 22 | 20111021 | 3 prime UTR variant | G/A | snv | 6.1E-02 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.020 | 1.000 | 2 | 2013 | 2018 | |||||||
|
22 | 20092080 | intron variant | A/G | snv | 0.40 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||||
|
22 | 20092080 | intron variant | A/G | snv | 0.40 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||||
|
22 | 20087052 | non coding transcript exon variant | C/T | snv | 0.12 |
|
Pathological Conditions, Signs and Symptoms | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||||
|
0.851 | 0.160 | 22 | 20111808 | 3 prime UTR variant | G/A | snv | 0.21 |
|
Behavior and Behavior Mechanisms | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.851 | 0.160 | 22 | 20111808 | 3 prime UTR variant | G/A | snv | 0.21 |
|
Behavior and Behavior Mechanisms | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.851 | 0.160 | 22 | 20111808 | 3 prime UTR variant | G/A | snv | 0.21 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.851 | 0.160 | 22 | 20111808 | 3 prime UTR variant | G/A | snv | 0.21 |
|
Behavior and Behavior Mechanisms | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.851 | 0.160 | 22 | 20111808 | 3 prime UTR variant | G/A | snv | 0.21 |
|
Infections; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.925 | 0.080 | 22 | 20111021 | 3 prime UTR variant | G/A | snv | 6.1E-02 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.925 | 0.080 | 22 | 20111021 | 3 prime UTR variant | G/A | snv | 6.1E-02 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
22 | 20111059 | 3 prime UTR variant | G/A | snv | 0.12 |
|
Pathological Conditions, Signs and Symptoms | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||||
|
1.000 | 0.080 | 22 | 20111359 | 3 prime UTR variant | T/C | snv | 0.22 |
|
Infections; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 |